← Leaderboards
Anbu Devasahayam
Eminent Services Corporation
$2,974,165
Attributed
$2,974,165
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,974,165 · 1
By mechanism
N01$2,974,165 · 1
Top collaborators
No co-investigators on record.
Most similar at Eminent Services Corporation
Same institution · by research overlap
- Raghuveera Yaramolu$10,131,923
Others in their field
Other Emerging Leaders on “Opioid”
- Chanza Baytop · Westat, Inc.$271,217,917
- Eve Jelstrom · The Emmes Company, Llc$36,024,078
- Jeffrey Reich · Sparian Biosciences, Inc.$28,894,251
- Xinhua Li · Nano Terra, Inc.$24,102,307
- Andrew S Huhn · Johns Hopkins University$19,514,484
- Emmanuel Aja Oga · Research Triangle Institute$17,470,090
Research focus
OpioidOrgan TransplantationPharmacologic SubstanceAllergic DiseaseProgramsRare DiseasesScheduleCell TransplantationClinical ResearchClinical TrialsAsthmaContractsAutoimmune DiseasesTissue TransplantationFoodFundingSolidImmuneServicesBasic ScienceIntervention StudiesVaccine TrialMediatingNational Institute Of Allergy And Infectious Disease
Grant awards (5)
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$775,000
N01 · FY2024 · AI · contact PI
NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$1,200,000
N01 · FY2023 · AI · contact PI
COVID Supplement NIAID DAIT CLINICAL PRODUCTS CENTER (CPC)$738,702
N01 · FY2022 · AI · contact PI
NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC)$91,235
N01 · FY2021 · AI · contact PI
NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC)$169,228
N01 · FY2020 · AI · contact PI